With the expansion of ThreatLocker’s deny-by-default approach to the cloud and mobile announced Thursday, the cybersecurity vendor is addressing one of the biggest challenges faced by MSPs today, CEO ...
Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag. Ben Hargreaves finds that the UK’s NICE is once again caught between ensuring ...
NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...
The 2026 Paris-Nice route was unveiled on December 17, with eight days of racing featuring 1,245km of racing and 16,460 metres of elevation gain. The route will take the peloton from Achères to Nice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results